Revenue: The sum of all revenue fields included for a company's operating activities.
Precision BioSciences, Inc. (DTIL) had Revenue of $68.70M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$68.70M |
$7.17M |
|
-- |
|
$68.70M |
|
$94.86M |
|
$-26.16M |
|
$33.33M |
|
$7.17M |
|
$7.60M |
|
$7.17M |
|
$7.17M |
|
$7.17M |
|
$7.60M |
|
$-26.16M |
|
$-22.28M |
|
6.83M |
|
6.88M |
|
$1.05 |
|
$1.04 |
|
| Balance Sheet Financials | |
$94.99M |
|
$3.09M |
|
$41.40M |
|
$136.39M |
|
$14.98M |
|
$22.32M |
|
$65.02M |
|
$80.00M |
|
$56.39M |
|
$55.77M |
|
$56.39M |
|
8.20M |
|
| Cash Flow Statement Financials | |
$-58.45M |
|
$-0.21M |
|
$50.45M |
|
$116.68M |
|
$108.47M |
|
$-8.21M |
|
$12.60M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.34 |
|
-- |
|
-- |
|
0.28 |
|
0.40 |
|
100.00% |
|
-38.08% |
|
-38.08% |
|
-32.43% |
|
10.43% |
|
10.43% |
|
$-58.63M |
|
-- |
|
-- |
|
-- |
|
0.50 |
|
-- |
|
299.98 |
|
1.22 |
|
12.71% |
|
12.85% |
|
5.25% |
|
9.11% |
|
$6.87 |
|
$-8.52 |
|
$-8.49 |
|